Imipenem / Cilastatin 500 mg / 500 mg powder for solution for infusion

Licence status
Authorised: 18/12/2020
Active substances
Imipenem, Cilastatin
Dosage Form
Powder for solution for infusion
Licence number
PA2059/074/002
Licence holder
Fresenius Kabi Deutschland GmbH

Product documents

Licence information

ATC code
J01DH51 imipenem and enzyme inhibitor
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
18/12/2020